Navigation Links
Spirus Medical Announces 510(k) Clearance from FDA for Expanded Use of Endo-Ease(R) Discovery SB(TM)
Date:5/18/2008

Unique 'rotate to advance' device enables deeper enteroscopy

SAN DIEGO, May 18 /PRNewswire/ -- Spirus Medical, Inc. (http://www.spirusmed.com), a leading developer of diagnostic and therapeutic advancement systems for gastroenterology and urology, announced at Digestive Disease Week 2008 that it has received 510(k) clearance from the FDA for an expanded indication for use with its Endo-Ease Discovery SB device in endoscopic procedures.

Spirus Medical has developed the Endo-Ease line of products aimed at revolutionizing GI endoscopy. The products' patented spiral feature promotes easier advancement of an endoscope, which helps physicians examine and treat GI disorders.

In clinical evaluations using a slim enteroscope, the Spirus Medical Endo-Ease Discovery SB proved effective in achieving an insertion depth of 400 cm beyond the Ligament of Treitz, and is now indicated to aid endoscopic insertion and advancement to the mid-ileum. Because physicians are able to provide better diagnosis and treatment with greater small bowel access, the Discovery SB is uniquely positioned to expand the capabilities of the endoscopist.

There are over twelve million EGD (esophagogastroduodenoscopy) procedures performed worldwide each year. A significant portion of those patients could benefit from an examination of the small bowel extending beyond the reach of gastroscopy, according to the company. Due to the limitations of existing technology, only a small fraction of these procedures are currently performed using an enteroscope to achieve greater insertion depth in the small bowel. The Spirus Endo-Ease Discovery SB addresses this emerging market opportunity, which could exceed $1 billion.

"Studies with the Endo-Ease Discovery SB show that safe and easy deep small bowel insertion is possible" said Dr. Paul Akerman, Director of Therapeutic Endoscopy and Endoscopic Oncology at Rhode Island Ho
'/>"/>

SOURCE Spirus Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ubstantially higher rates of mental health problem...s from a systematic review and meta-analysis publi...or studies over the past four decades containing d...ess people, Seena Fazel and colleagues of the Univ...,684 homeless individuals based in the US, UK, mai...
(Date:12/2/2008)...mposium today hosted by Johns,Hopkins University...s presented,the latest research in brain plastici... into technology to improve lives. Henry Mahncke, ...e that cognitive intervention developed by,Posit ...s ability to,reorganize itself throughout life. ...
(Date:12/2/2008)... assault are unsettling; the Department of Justice...e victim of attempted or actual sexual assault dur...rs from two universities, including the University...are unaware of drug-facilitated sexual assault and...including leaving drinks unattended. , "These f...
(Date:12/2/2008)...rprise software and online services veteran is exp...ers of Yugma,s instant web conferencing solutions ... December 2, 2008 -- Yugma , the leading web conf...aborate instantly using the Internet, announced th... Officer. , , ,Vas has more than 20 years of exper...
Breaking Medicine News(10 mins):Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3
... dengue cases in the national capital civic author...k the menace//, including prosecuting people who c...v, deputy municipal health officer of Delhi said, ...ted of which six proved to be fatal. We have recei...
...ealthcare treatment meted to those suffering menta...udy has found.// An investigation of 8 million hea...s opened a can of worms. The study spanning 18 m... a propensity suffer other illness alongside, as c...
...re is a “crisis” over lack of donors at sperm bank...linics being totally out of stock//, women and cou...problem. In 1990s, the highest number of donors w...decreasing. To make it worse, last year a new law ...
... reduce the bio-terrorism threat of the Venezuelan...hers at the University of Texas Medical Branch at ...al step in the development of effective drug thera...litis (VEE) virus, which is a potential bio-terror...
Other Medicine News:Health News:Shortage of donors at sperm bank clinics 2Health News:A New drug Developed To Fight The Bio-Terrorism Threat Of VEE Virus 2
(Date:12/1/2008)...PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc...ncet , one of the world,s leading medical journals...n regulator, experimental compound tasimelteon (VE... entitled "Melatonin agonist tasimelteon (VEC-162)...o randomised controlled multicentre trials." Resul...
(Date:12/1/2008)...hatasia Treated With ENB-0040 at Children,s Hospit...MONTREAL, Dec. 1 Enobia Pharma, an...loping novel therapeutics for serious bone disorde...in its clinical program for hypophosphatasia was d...herapy (ERT) with ENB-0040 for the treatment of th...
(Date:12/1/2008)...December 1 Following a,...t to procure an MVA-based,third generation small...,Canada, on behalf of the Canadian Department of N...an Nordic for the delivery of IMVAMUNE(R). , ...R) as part of the,country,s bio-preparedness prog...
(Date:11/30/2008).... 1 Older adults who ex...w and a greater number of small blood vessels in t... the annual meeting of the Radiological Society of...ucted at the University of North Carolina ( UNC)...ns of older adults who exercise to brain scans of ...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Thyroid Hormone Could One Day Treat Osteoporosis 13954 1Thyroid Hormone Could One Day Treat Osteoporosis 13954 2Thyroid Hormone Could One Day Treat Osteoporosis 13954 3Alarming growth in expected CO2 emissions in China finds UC analysis 2451 1Alarming growth in expected CO2 emissions in China finds UC analysis 2451 2Alarming growth in expected CO2 emissions in China finds UC analysis 2451 3GFX 3A Wrinkle Killer or Botox 28R 29 Hit Man 3F 13950 1GFX 3A Wrinkle Killer or Botox 28R 29 Hit Man 3F 13950 2GFX 3A Wrinkle Killer or Botox 28R 29 Hit Man 3F 13950 3Injection of human umbilical cord blood helps the aging brain 13948 1Injection of human umbilical cord blood helps the aging brain 13948 2
...ay 29, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) ...007) study of aztreonam lysine for inhalation for,...who have,pulmonary Pseudomonas aeruginosa (P. aeru...e at Day 28 from baseline in respiratory,symptoms,...Revised,(CFQ-R), a patient-reported outcome (PRO) ...
...for Organ Transplantation, HORSHOLM, Denmark, May ...a announces positive Phase I clinical results for,... Heads into US,Phase II clinical trials for organ ...:LCP) announces positive results,from its Phase I ..., once-daily tacrolimus tablet. , A series of Phas...
Other Medicine Technology:Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 2Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 3Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 4Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 5LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
MONOJECT Red/Yellow Mottled Stopper
BD Vacutainer® Specialty Tubes - Thrombin
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
Medicine Products: